IDYA Ideaya Biosciences


Data from SEC filings
Employee count

Shareholder alignment

Proxy contests and exempt solicitations in last 3 years

No recent proxy contest or exempt solicitation filings from shareholders.

Vote support at last AGM
On June 10, 2021, IDEAYA Biosciences, Inc. (the “Company”) held its 2021 Annual Meeting of Stockholders (the “Annual Meeting”). At the Annual Meeting, the Company’s stockholders voted on two proposals, each of which is described in more detail in the Company’s definitive proxy statement on Schedule 14A filed with the Securities and Exchange Commission on April 19, 2021. Only stockholders of record as of the close of business on April 16, 2021, the record date for the Annual Meeting, were entitled to vote at the Annual Meeting. As of the record date, 32,905,592 shares of the Company’s common stock were outstanding and entitled to vote at the Annual Meeting. The tabulation of the stockholder votes on each proposal brought before the Annual Meeting is as follows:

Proposal 1. The election of three Class II directors to hold office until the 2024 annual meeting of stockholders or until their respective successors are elected:

NomineeVotes ForVotes WithheldBroker

Timothy M. Shannon, M.D.24,111,7591,638,6042,678,718
Terry J. Rosen, Ph.D.24,000,7981,749,5652,678,718
Wendy L. Yarno24,111,0861,639,2772,678,718

Proposal 2. The ratification of the selection, by the Audit Committee of the Board of Directors of the Company, of PricewaterhouseCoopers LLP as the independent registered public accounting firm of the Company for the year ending December 31, 2021:

Votes ForVotes AgainstAbstentions

As a routine proposal under applicable rules, no broker non-votes were recorded in connection with this proposal.